Copy
View this email in your browser
Share Share
Tweet Tweet
Forward Forward

NICE News

Bringing you our latest news, features and guidance.
August 2021
COVID-19NewsInto practice | Get involved | Blogs | Events | Announcements

COVID-19

New rapid guideline on rare blood clotting syndrome associated with COVID-19 vaccination

We've published a new COVID-19 rapid guideline on vaccine-induced immune thrombocytopenia and thrombosis (VITT). The guideline aims to help healthcare staff identify and treat patients who develop this rare syndrome after receiving COVID-19 vaccinations. It outlines:

  • how to identify people with suspected VITT
  • what tests should be carried out 
  • treatment options
  • reporting procedures.
Read VITT rapid guideline

News

Pregnant woman holding her bump.
Woman having a mammogram.

Care throughout pregnancy

Our updated antenatal care guideline offers practical advice on the routine care of women and their babies during pregnancy. For the first time, the guideline addresses the role that partners can play in supporting women through their pregnancy. It includes recommendations about how to involve them in antenatal appointments and what information to give.

Abemaciclib for advanced breast cancer

We've published draft guidance recommending abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy. The positive recommendation follows an improved patient access scheme, along with further economic modelling data provided by the manufacturer.

Woman and child in a wheelchair at a table painting a picture.
Man with prosthetic leg and lady health professional walking in rehab ward.

Disabled children and young people with complex needs

Our new draft guideline makes recommendations on how services should work for disabled children and young people up to the age of 25 with severe complex needs. It supports joined up health, social and education services. Consultation on the draft guideline is open until Tuesday 14 September.

Rehabilitation after traumatic injury

Effective rehabilitation following traumatic injury can help patients to get back to the best possible level of function and independence. Our draft guideline recommends ways to help people resume their life, whether that involves work, education or activities. Consultation on the draft guideline is open until Wednesday 8 September.

Piloting a new fast track approach for a limited number of technology appraisals 

We are piloting a new fast track approach to the assessment of eligible low-risk treatments. Due to the COVID-19 pandemic, in 2020 we paused production of some of our guidance. Since then, we've been working hard to develop and publish the guidance affected. By using fewer committee members and comparing the technology being appraised to similar therapies that we've already evaluated, our pilot programme is enabling us to make decisions more quickly.

Catch up on all our latest news articles
NICE Talks logo.

Our proposed changes to health technology evaluation

In this month's podcast, we discuss our health technology evaluation methods, processes and topic selection consultation. We chat with NICE's deputy chief executive and director of the Centre for Health Technology Evaluation, Meindert Boysen, and Victoria Barrett from The Association of the British Pharmaceutical Industry. They talk about what the proposals mean for patients, the NHS and industry, and whether they go far enough.

Into practice

New collaboration between NICE and The Academic Health Science Network

NICE and The Academic Health Science Network (AHSN) have announced a new 2-year collaboration. Priority areas of work outlined in the agreement include:

  • addressing market challenges for digital innovation
  • shaping and generating real-world evidence
  • improving the lives of patients by supporting the best innovations to gain access to the healthcare system.
We've previously worked with The AHSN Network to support and accelerate the rate of adoption and spread of evidence-based practice and innovation in the NHS. This formalised agreement will focus on drawing together the expertise and resources of both organisations to deliver these improvements more effectively.

Get involved

NICE launches final consultation on proposed changes to health technology evaluation

NICE is changing its approach to health technology evaluation.

A public consultation on our methods, processes and topic selection for health technology evaluation is open until 11:59pm on Wednesday 13 October 2021.

This short animation summarises our proposed changes to health technology evaluation.
A series of virtual events will explain our proposals in more detail:
  • Methods focus, Tuesday 24 August 2021, 4pm to 5pm. 
  • Highly specialised technologies selection criteria focus, Wednesday 1 September 2021, 4pm to 5pm.
  • Process and topic selection proposals, Wednesday 8 September 2021, 1pm to 2pm.
  • Methods review - a focus on modifiers, Thursday 9 September 2021, 2pm to 3pm.
Learn more about our proposals

Help us improve how we write and present our guidance

We are reviewing how we write and present our guidance to ensure it is accessible and clear. We need your help to understand:

  • how you use our recommendations
  • what you want to know about the reasoning and evidence behind our recommendations.

Please take 15 minutes to complete our short survey, which is open until Friday 10 September 2021.

Complete survey
Our initial work is focusing on the type 2 diabetes in adults guideline but you do not need to be an expert in this topic to help shape our future content.

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
 
See all our open consultations

Join a committee

We have a number of vacancies for health professionals and lay people to join our committees. Topics include osteoporosis, falls in older people and medical technologies. Join us and have an active role in producing a guideline or quality standard.

See our current committee vacancies

Observe a meeting

Due to the pandemic, we're holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Tuesday 7 September 2021 – Indicator advisory committee
    Registration closes Tuesday 31 August 2021.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings

Blogs

Cogs on a computer screen.

A new multi-agency advisory service for AI and data-driven technologies

In this NHSX hosted blog post, senior leaders from NICE, the Care Quality Commission, Medicines and Healthcare products Regulatory Agency and the Health Research Authority reveal plans to develop the world’s first cross-regulatory advisory service for developers and adopters of artificial intelligence (AI) and other data-driven technologies.

Events

Innovation in medicines: adapting for the future

The King's Fund is holding a free virtual event:

  • Innovation in medicines: adapting for the future, Tuesday 21 September 2021, 2pm to 3pm. 
NICE chairman, Sharmila Nebhrajani, is speaking at the event. She will discuss our role in the future of innovation within research, medicines and the NHS.
Register for your free ticket

Announcements

Publication of ME/CFS guideline paused

NICE used its usual rigorous approach to develop an updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS). However, despite the best efforts of the committee and patient groups, we have not been able to produce a guideline that is supported by all. 

The causes of ME/CFS are still poorly understood and because of this, there are strong views around the management of this debilitating condition. Due to issues raised during the pre-publication period, we need to take time to consider next steps. We will hold conversations with professional and patient stakeholder groups to do this. We need to do this so that the guideline is supported and can be successfully implemented.

Annual report and accounts 2020/21

We’ve published our annual report and accounts. During a year in which the nation faced extraordinary difficulties, our evidence-based information, about what good care looks like and how it can best be delivered, has been more vital than ever.

In this short animation, we outline some of the ways in which we’ve been supporting improved patient access to innovative medicines and technologies during 2020/21.
Instagram
Instagram
Facebook
Facebook
Twitter
Twitter
SoundCloud
SoundCloud
YouTube
YouTube
LinkedIn
LinkedIn

unsubscribe from this list